February 1, 2017 NIAID Funding News
Read this full issue online at https://www.niaid.nih.gov/
Feature Articles
NIAID Strives To Maintain Speedy Time To Award
Several factors impact how quickly an application progresses from receipt date to summary statement to award, most significantly the institute to which and the Council round for which you apply.
Opportunities and Resources
Study Immune Response Role of Natural Killer Cells in HIV-1 Vaccine Design
Through a new R01 funding opportunity announcement, NIAID seeks novel approaches to harness natural killer cell immunoregulatory functions in HIV-1 vaccine design and enhance protective HIV-1 specific adaptive immune responses.
HIV Vaccine Researchers: A Funding Opportunity for Your Consideration
Gaining a deeper understanding of the underlying immune mechanism of vaccine protection is vital to improving the efficacy of vaccines, the most promising long-term method of controlling the HIV/AIDS epidemic.
Study HIV-1 Infection of the Central Nervous System
Get up to five years of R01 funds to study pathogenic mechanisms involved in HIV-1 induced central nervous system dysfunction.
In The News
Notes on Implementation of Final-RPPR
We want to emphasize a few details about implementation of the new policy.
News Briefs
- NIAID To Co-Host Workshop on Antibiotic Discovery for Gram-Negative Bacteria
- Attend International Grants Policy Training Workshops in China or Spain
- Pamela Guerrerio Receives Presidential Honor
Advice Corner
Caution: Roles Determine Eligibility and Other Requirements
The scientific community uses many terms to describe different roles on a project. However, some terms aren’t used by NIH or are terms that cause confusion.
Reader Questions
- What factors are used to evaluate a contract proposal?
- For investigators with R01 funding, are there limits on the salaries of postdoctoral assistants and technicians?
New Funding Opportunities
- PA-17-085, Zika Virus (ZIKV) Complications (R21)
- RFA-NS-17-021, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54)
- RFA-NS-17-022, Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24)
- PAR-17-142, International Research in Infectious Diseases, including AIDS (R01)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario